Stacy Henderson, MD
Plastic and Reconstructive Surgery · New Orleans, LANPI 1457618316
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.3%), food and beverage and other — rather than concentrated in one kind of arrangement. Axogen accounts for 62.4% of it on its own, with 7 other manufacturers making up the rest.
Across 18 payments — averaging $165.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Integra Lifesciences Corporation$830
- Smith+Nephew$99
- AbbVie$71
- Baxter Healthcare$59
- Pacira Pharmaceuticals Incorporated$31
- plus $31 from 2 others
What the payments were for
- Travel & lodging$1,44148%
- Food & beverage$89130%
- Other$65222%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 3 | $1,862 |
| Integra Lifesciences Corporation | 6 | $830 |
| Smith+Nephew | 1 | $99 |
| AbbVie | 1 | $71 |
| Baxter Healthcare | 3 | $59 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| BD | 1 | $16 |
| Cook Medical LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,984 in reported general payments places this provider in the 55th percentile of 45 plastic and reconstructive surgery providers in Louisiana.
See all plastic and reconstructive surgery providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in New Orleans
- Omer KaymakcalanNew Orleans$10K
- Suma MaddoxNew Orleans$6K
- William AukermanNew Orleans$6K
- Christopher SmithNew Orleans$5K
- Vidhur SohiniNew Orleans$5K
- Christopher BabycosNew Orleans$5K
- Daniel YooNew Orleans$4K
- Michael MosesNew Orleans$4K
- Katherine ChiassonNew Orleans$3K
- Heath CharvetNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.